5-AMINO-1MQ 50mg Capsules

5-AMINO-1MQ 50mg Capsules contain 5-amino-1-methylquinolinium, an experimental small-molecule NNMT inhibitor studied primarily in metabolic and adipose tissue research. Despite often appearing alongside research peptides, 5-Amino-1MQ is not a peptide. Its main research target is the enzyme nicotinamide N-methyltransferase (NNMT).

Interest in 5-Amino-1MQ centres on the role NNMT plays in nicotinamide metabolism, NAD+ availability and the metabolic behaviour of fat cells. Preclinical studies have investigated inhibiting NNMT in white adipose tissue, including models of diet-induced obesity.

What Is 5-Amino-1MQ?

5-Amino-1MQ is a synthetic small molecule developed to inhibit nicotinamide N-methyltransferase (NNMT). NNMT is an enzyme that transfers a methyl group from S-adenosylmethionine (SAM) to nicotinamide, producing 1-methylnicotinamide (1-MNA).

This reaction is important to researchers because nicotinamide can also be recycled through the NAD+ salvage pathway. NAD+ is a coenzyme involved in cellular energy metabolism, redox reactions and the activity of NAD+-dependent enzymes.

Rather than supplying NAD+ or acting as an NAD supplement, 5-Amino-1MQ provides researchers with a way of studying what happens when one pathway that consumes nicotinamide is inhibited.

Why Is 5-Amino-1MQ Researched?

A major area of interest is adipose tissue. NNMT expression and activity have been linked with metabolic changes in white adipose tissue, making the enzyme a potential target for investigating how fat cells store and process energy.

5-Amino-1MQ has therefore been used in laboratory and animal models to examine NNMT inhibition without directly targeting appetite-related receptors.

This distinction is particularly relevant when discussing appetite suppression. In a widely cited study involving diet-induced obese mice, researchers observed reductions in body weight and white adipose tissue without a significant change in food intake. This suggests the findings could not simply be explained by the animals consuming less food.

What Have Studies Found?

Preclinical research has produced some of the most interesting findings around fat mass and adipocyte structure.

In diet-induced obesity models, researchers have investigated outcomes including:

• Reduced white adipose tissue mass
• Smaller fat cells
• Changes in overall fat cell size
• Reduced lipogenesis in cultured adipocytes
• Changes in body weight without significantly reduced food intake
• Alterations in NAD+ concentrations following NNMT inhibition

The observation of smaller fat cells is particularly relevant to the mechanism being studied. Instead of simply measuring total body weight, researchers were able to examine changes directly within adipose tissue.

These results come from preclinical models. There are currently no published controlled human trials establishing 5-Amino-1MQ as a treatment for reducing fat mass or producing long-term weight loss in people.

5-Amino-1MQ And NAD Levels

The relationship between NNMT and NAD+ provides another distinct area of research.

NNMT uses nicotinamide to produce 1-MNA. Nicotinamide can alternatively act as a precursor within the NAD+ salvage pathway, so researchers have investigated whether inhibiting NNMT changes intracellular NAD levels.

Experiments involving cultured adipocytes have reported increased intracellular NAD+ concentrations following NNMT inhibition with 5-Amino-1MQ. The original research reported concentration-dependent increases of approximately 1.2 to 1.6-fold under the experimental conditions studied. :contentReference[oaicite:1]{index=1}

NAD+ participates in numerous cellular processes, including mitochondrial function and cellular energy metabolism. It is also required by enzymes including sirtuins.

However, 5-Amino-1MQ should not be described as directly causing sirtuin activation. The research interest instead comes from whether changing NAD+ availability through NNMT inhibition could influence NAD+-dependent cellular pathways.

Fat Oxidation And Energy Expenditure Research

Another area being investigated is the relationship between NNMT and the way adipose tissue handles stored energy.

Research into NNMT has examined metabolic processes involving lipogenesis, fat oxidation and energy expenditure. These processes determine whether nutrients are stored within adipocytes or used to meet cellular energy requirements.

This provides a possible metabolic explanation for why changes in adipose mass and fat cell size have been observed without corresponding appetite suppression in animal experiments.

Researchers are also interested in the wider relationship between NAD+ metabolism, mitochondrial function and cellular energy. These pathways are closely connected, but findings from experimental models should not be treated as evidence of increased human metabolism or proven fat-burning effects.

Why White Adipose Tissue Matters

White adipose tissue does considerably more than store excess energy. It is metabolically active tissue involved in nutrient storage, hormone signalling and wider metabolic regulation.

Changes in the size and behaviour of adipocytes can therefore provide researchers with more information than changes in total body weight alone.

By inhibiting NNMT, 5-Amino-1MQ allows researchers to examine how this enzyme contributes to adipocyte metabolism and whether changing its activity alters the balance between energy storage and utilisation.

This focus on cellular metabolism separates 5-Amino-1MQ research from compounds primarily investigated through appetite, GLP-1 or central nervous system pathways.

Quality Control & Capsule Format

5-AMINO-1MQ 50mg Capsules provide the compound in a capsule-based research format. Because 5-Amino-1MQ is a chemically defined small molecule rather than a peptide, its analytical profile and quality control requirements are different from conventional peptide products.

Compound identity, purity and chemical form should be assessed against the applicable batch documentation and Certificate of Analysis where provided.

This is particularly important with 5-Amino-1MQ because different salt forms may be referenced by suppliers, resulting in differences in molecular formula and molecular weight. The specification for the individual batch should therefore take priority over generic values found online.

Storage

5-AMINO-1MQ 50mg Capsules should be stored according to the conditions specified within the applicable product and batch documentation. Keep the formulation protected from excessive heat, direct light and moisture and maintain consistent conditions during laboratory storage.

Long-term human safety and effectiveness have not been established.

Disclaimer: This product is supplied strictly for research use only. Not intended for human or veterinary use or consumption.